Helix and St. Luke’s Launch Genomic Program to Lower Healthcare Costs

Helix has expanded its partnership with St. Luke’s University Health Network to launch Helix Genomic Advantage, announced in a press release. The initiative is described as the first genomic benefit program aimed at improving access to precision medicine while lowering total medical costs.

St. Luke’s is the first health system in the United States to offer the program to its workforce. Helix Genomic Advantage integrates germline genomics into routine care and removes administrative barriers such as prior authorizations. It also uses Helix’s Sequence Once, Query Often platform to provide genomic insights across the care delivery system.

The program is designed to improve quality outcomes and reduce adverse events, with Helix stating that it aligns its incentives with participating health systems to achieve measurable savings within the first year.